ELEV NASDAQ
Elevation Oncology, Inc.
1W: +0.0%
1M: -3.6%
3M: +7.3%
1Y: -86.7%
3Y: -74.1%
$0.36
Last traded 2025-08-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-34.5% YoY
$-48M
Net Income
-21.9% YoY
$-31M
Free Cash Flow
+36.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-78.3%
ROA-50.2%
ROIC1450.2%
Valuation
P/E-0.5
P/B0.3
EV/EBITDA0.7
Leverage
Debt/Equity0.67
Current Ratio19.40
Interest Cov.-12.1x
Quality Scores
Piotroski F1/9
Altman Z-4.82
Beneish M0.00